Dr.Reddy’s Laboratories Ltd announced that it has completed the acquisition of select divisions of WockhardtNSE -4.33 % Limiteds branded generics business in India and a few other international territories of Nepal, Sri Lanka, Bhutan and Maldives. The business comprises a portfolio of 62 brands in multiple therapy areas such as Respiratory, Neurology, VMS, Dermatology, Gastroenterology, Pain and Vaccines, which would transfer to Dr Reddys along with related sales and marketing teams and a manufacturing plant located in Baddi, Himachal Pradesh with all plant employees, a press release from the drug maker said.
Dr Reddy’s completes the acquisition of Wockhardt’s select generics, plant
Date posted: Friday 3 July 2020